Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inhibitors”

3,652 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 3,652 results

Testing effectiveness (Phase 2)Study completedNCT03647839
What this trial is testing

Modulation Of The Tumour Microenvironment Using Either Vascular Disrupting Agents or STAT3 Inhibition in Order to Synergise With PD1 Inhibition in Microsatellite Stable, Refractory Colorectal Cancer

Who this might be right for
Colorectal Cancer Metastatic
Australasian Gastro-Intestinal Trials Group 90
Large-scale testing (Phase 3)Ended earlyNCT03626545
What this trial is testing

Phase III Study Evaluating Efficacy and Safety of Canakinumab in Combination With Docetaxel in Adult Subjects With Non-small Cell Lung Cancers as a Second or Third Line Therapy

Who this might be right for
Non-Small-Cell Lung
Novartis Pharmaceuticals 245
Testing effectiveness (Phase 2)Study completedNCT01276353
What this trial is testing

A Study Versus E2020 10mg Followed by an Open-label Extension Phase to Explore the Safety of E2020 SR 23 mg in Japanese Subjects With Severe Alzheimer's Type Dementia

Who this might be right for
Alzheimer's Type Dementia
Eisai Inc. 45
Post-approval studies (Phase 4)Study completedNCT02509312
What this trial is testing

Prospective Effect of Intravenous Ketorolac on Opioid Use, EBL and Complications Following Cesarean Delivery

Who this might be right for
Analgesia, ObstetricalPostpartum HemorrhageOpioid Use+5 more
University Hospitals Cleveland Medical Center 70
Large-scale testing (Phase 3)Study completedNCT03452865
What this trial is testing

Esomeprazole to Reduce Organ Failure in Sepsis

Who this might be right for
SepsisSeptic Shock
Università Vita-Salute San Raffaele 300
Not applicableStudy completedNCT01266265
What this trial is testing

Study of Incidence of Respiratory Tract AEs in Patients Treated With Tyvaso® Compared to Other FDA Approved PAH Therapies

Who this might be right for
Pulmonary Arterial Hypertension
United Therapeutics 1,333
Not applicableApproved For MarketingNCT03154437
What this trial is testing

An Expanded Access Program of Emicizumab in Participants With Hemophilia A With Inhibitors

Who this might be right for
Hemophilia A
Genentech, Inc.
Early research (Phase 1)Looking for participantsNCT07053319
What this trial is testing

SGLT2i, Pioglitazone, and Ketone Production in T2D

Who this might be right for
Type 2 Diabetes
The University of Texas Health Science Center at San Antonio 64
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07376499
What this trial is testing

Prospective, Single-arm, Phase II Clinical Study of Irinotecan Hydrochloride Liposome Injection Combined With Platinum and Immune Checkpoint Inhibitors Combined With Anlotinib for the Maintenance of Extensive Small Cell Lung Cancer After First-line Induction

Who this might be right for
Small Cell Lung Cancer
China Medical University, China 31
Not applicableLooking for participantsNCT06858384
What this trial is testing

RAK-PRIDE: Optimizing Proton Pump Inhibitor Use Through Education and Intervention

Who this might be right for
Proton Pump InhibitorsDeprescribingInappropriate Use
RAK Medical and Health Sciences University 479
Post-approval studies (Phase 4)Not Yet RecruitingNCT07004335
What this trial is testing

Efficacy and Safety of Iparomlimab and Tuvonralimab Injection in Combination With Bevacizumab After Progression on Anti-PD-(L)1 Therapy in Advanced Melanoma: A Prospective, Single-Arm, Exploratory Clinical Study

Who this might be right for
PD-(L)1CTLA-4Advanced Melanoma+3 more
Hebei Medical University Fourth Hospital 40
Testing effectiveness (Phase 2)Ended earlyNCT04738292
What this trial is testing

Onapristone and Fulvestrant for ER+ HER2- Metastatic Breast Cancer After Endocrine Therapy and CDK4/6 Inhibitors (The SMILE Study)

Who this might be right for
ER-positive Breast CancerHER2-negative Breast CancerMetastatic Cancer
University of Wisconsin, Madison 11
Testing effectiveness (Phase 2)Not Yet RecruitingNCT03867487
What this trial is testing

SGLT2 Inhibitors as a Novel Treatment for Pediatric Non-Alcoholic Fatty Liver Disease

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNAFLDPediatric NAFLD
Justin Ryder 40
Testing effectiveness (Phase 2)Looking for participantsNCT06576921
What this trial is testing

Efficacy and Safety of Serplulimab Combined With Chemotherapy as Neoadjuvant Treatment for Locally Advanced Gastric Cancer or Adenocarcinoma of Esophagogastric Junction

Who this might be right for
Stomach NeoplasmsImmune Checkpoint Inhibitors
Xijing Hospital 116
Not applicableStudy completedNCT00178607
What this trial is testing

Covalent Tolerance Induction to Factor VIII-Prediction of Inhibitors in Hemophilia

Who this might be right for
Hemophilia A
The University of Texas Health Science Center, Houston 99
Not applicableStudy completedNCT02191293
What this trial is testing

Long-term Study in Patients Under Anti-retroviral Combination Therapy Switching to Viramune®

Who this might be right for
HIV Infections
Boehringer Ingelheim 228
Not applicableUnknownNCT01383304
What this trial is testing

Aspirin Response in High Risk Patients With Coronary Artery Disease

Who this might be right for
Coronary Artery DiseaseMyocardial InfarctionDiabetes Mellitus+1 more
University of Aarhus 906
Testing effectiveness (Phase 2)UnknownNCT03048500
What this trial is testing

Nivolumab and Metformin Hydrochloride in Treating Patients With Stage III-IV Non-small Cell Lung Cancer That Cannot Be Removed by Surgery

Who this might be right for
Recurrent Non-Small Cell Lung CarcinomaStage III Non-Small Cell Lung CancerStage IIIA Non-Small Cell Lung Cancer+2 more
Northwestern University 17
Large-scale testing (Phase 3)Study completedNCT06414707
What this trial is testing

Efficacy of Vonoprazan in Eradication of Resistant Strain of Helicobacter Pylori

Who this might be right for
Helicobacter Pylori Infection
Ain Shams University 320
Testing effectiveness (Phase 2)UnknownNCT03994393
What this trial is testing

Non Small Cell Lung Cancer Trial of Durvalumab and Tremelimumab in Advanced Epidermal Growth Factor Receptor (EGFR) Mutant Disease.

Who this might be right for
EGFR Mutant Advanced Non Small Cell Lung Cancer
University of Sydney 100
Load More Results